SC
BHVN icon

Stempoint Capital’s Biohaven BHVN Stock Holding History

Stempoint Capital’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$525K Buy
+500,000
New +$5.38M 0.09% 74
2025
Q4 		– Sell
-480,000
Closed -$1.19M – 87
2025
Q3 		$1.19M Buy
+480,000
New +$6.99M 0.24% 60

Other funds holding BHVN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Stempoint Capital's BHVN Position: Q2 2026 in Review

Stempoint Capital reduced its Biohaven (BHVN) stake by 33% in Q2 2026, selling an estimated $5.71M and leaving 1,064,200 shares worth $15.8M. The position accounts for 2.73% of the portfolio, ranked #9.

Stempoint Capital first reported a position in BHVN in Q4 2023 and has held it in 10 quarters since. 296 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • Stempoint Capital held 1,064,200 shares of Biohaven worth $15.8M as of Q2 2026.
  • Stempoint Capital sold 530,291 Biohaven shares in Q2 2026, an estimated $5.71M.
  • Biohaven made up 2.73% of Stempoint Capital's portfolio in Q2 2026, its #9 holding.
  • Stempoint Capital first reported a position in Biohaven in Q4 2023 and has held it in 10 quarters since.
  • 296 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Stempoint Capital's 13F filing for Q2 2026, filed 14 Aug 2026.